S
Power Law company profile
Stemcentrx
Biotech & Life Sciences · South San Francisco, United States · Founded 2008 Decacorn
Patent intelligence
$51M patent portfolio · 20 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$51M
0.50% of valuation · 15.4× smaller than top peer BioNTech ($780M)
20 active patent families
Where Stemcentrx innovates
Molecular biologyAntiendomysial antibodiesAntibody-drug conjugatePharmaceutical drugImmunology
Below peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
Stemcentrx on the five Patsnap quality dimensions
Stemcentrx in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Stemcentrx concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Stemcentrx and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Stemcentrx on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.